Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

SIRT2-IN-9

😃Good
Catalog No. T62515Cas No. 522650-91-5

SIRT2-IN-9 is a selective SRIT2 inhibitor with an IC50 value of 1.3 μM.SIRT2-IN-9 inhibits the proliferation of MCF-7 breast cancer cells.SIRT2-IN-9 can be used for cancer research.

SIRT2-IN-9

SIRT2-IN-9

😃Good
Purity: 97.6%
Catalog No. T62515Cas No. 522650-91-5
SIRT2-IN-9 is a selective SRIT2 inhibitor with an IC50 value of 1.3 μM.SIRT2-IN-9 inhibits the proliferation of MCF-7 breast cancer cells.SIRT2-IN-9 can be used for cancer research.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$68-In Stock
10 mg$118-In Stock
25 mg$247-In Stock
50 mg$392-In Stock
100 mg$588-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:97.6%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
SIRT2-IN-9 is a selective SRIT2 inhibitor with an IC50 value of 1.3 μM.SIRT2-IN-9 inhibits the proliferation of MCF-7 breast cancer cells.SIRT2-IN-9 can be used for cancer research.
Targets&IC50
SIRT2:1.3 μM, SIRT3:>300 μM, SIRT1:>300 μM
In vitro
SIRT2-IN-9 (1-100 μM; 15 min) dose-dependently inhibits SIRT2 (IC50=1.3 μM) while also inhibiting SIRT1 and SIRT3 (IC50s >300 μM).[1] Additionally, SIRT2-IN-9 (0-50 μM; 72 h) affects the cell viability and dose-dependently inhibits the proliferation of MCF-7 breast cancer cells.[1] SIRT2-IN-9 (0-50 μM; 6 h) also impacts the acetylation of α-tubulin protein.[1]
Chemical Properties
Molecular Weight438.57
FormulaC21H22N6OS2
Cas No.522650-91-5
SmilesCCCn1c2ccccc2c2nnc(SCC(=O)Nc3nc4CCCCc4s3)nc12
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 4 mg/mL (9.12 mM), Sonication and heating to 70℃ are recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.2801 mL11.4007 mL22.8014 mL114.0069 mL
5 mM0.4560 mL2.2801 mL4.5603 mL22.8014 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy SIRT2-IN-9 | purchase SIRT2-IN-9 | SIRT2-IN-9 cost | order SIRT2-IN-9 | SIRT2-IN-9 chemical structure | SIRT2-IN-9 in vitro | SIRT2-IN-9 formula | SIRT2-IN-9 molecular weight